Latest Strategic Reviews News

Bowen Coking Coal has announced it will remain suspended on the ASX as it reassesses its operational plans and explores financing options amid challenging market conditions.

Opyl Limited has taken a bold step into digital assets by acquiring approximately 2 Bitcoin and securing a $2 million finance facility backed by these holdings, signaling a strategic pivot towards blockchain integration in healthcare technology.

Strike Energy unveils a strategic pivot focusing on gas-fired power and upstream gas projects to underpin Western Australia’s energy transition and deliver shareholder value.

Fletcher Building unveiled a comprehensive strategic review and FY25 outlook at its Investor Day, highlighting a focus on manufacturing and distribution alongside significant restructuring costs. The company targets a leaner operation with disciplined capital management and a net debt goal of NZD 400m to 900m.

Euroz Hartleys Group Limited has announced a proposed $23 million capital return to shareholders, pending approval at a July 2025 meeting, aiming to streamline its corporate structure while maintaining financial strength.

FireFly Metals Ltd has announced a flow-through share offer aiming to raise approximately A$11.2 million, targeting Canadian investors to fund regional exploration drilling. This offer complements a broader capital raising strategy to advance development at the Ming Mine and other key projects.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Fletcher Building has confirmed it is fielding inquiries from potential buyers following its strategic review announcement, though no sales decisions have been made. Investors await clarity at the upcoming Investor Day.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.